Sanofi (SNYNF) Income from Continuing Operations (2009 - 2026)

Sanofi has reported Income from Continuing Operations for 18 years, with the latest figure at 17108804128.44 in Q2 2026.

• Quarterly Income from Continuing Operations rose 21.97% year-over-year to 17108804128.44 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 92241628000.43 (up 88.39% YoY) and the FY2025 annual result came in at 5973871317.43, up 66.88% from the prior year.
• Income from Continuing Operations rose to 17108804128.44 in Q2 2026 per SNYNF's latest filing, from 14931690021.08 in the prior quarter.
• Over five years, Income from Continuing Operations peaked at 50289431345.79 in Q4 2023 and troughed at 6152972314.14 in Q4 2024.
• A 5-year average of 18789437046.11 and a median of 13999047358.5 in 2025 frame the typical range for Income from Continuing Operations.
• The sharpest annual moves came in 2022 and 2024: Income from Continuing Operations jumped 2253.86% in 2022, then plunged 87.76% in 2024.
• Over 5 years, Income from Continuing Operations stood at 41559776425.37 in 2022, then grew by 21.01% to 50289431345.79 in 2023, then slumped by 87.76% to 6152972314.14 in 2024, then soared by 127.06% to 13970850263.41 in 2025, then increased by 22.46% to 17108804128.44 in 2026.
• According to Business Quant data, Income from Continuing Operations over the past three periods registered 17108804128.44, 14931690021.08, and 13970850263.41 for Q2 2026, Q1 2026, and Q4 2025 respectively.